James Investment Research’s Teva Pharmaceuticals TEVA Stock Holding History

James Investment Research’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,959	Closed	-$918K	–	591
2016 Q3	$918K	Sell	19,959 -15,995	-44%	-$835K	0.02%	255
2016 Q2	$1.81M	Sell	35,954 -21,555	-37%	-$1.15M	0.05%	206
2016 Q1	$3.08M	Buy	57,509 +650	+1%	+$38.1K	0.08%	165
2015 Q4	$3.73M	Buy	56,859 +3,660	+7%	+$226K	0.09%	156
2015 Q3	$3M	Sell	53,199 -995	-2%	-$64.5K	0.08%	157
2015 Q2	$3.2M	Sell	54,194 -1,520	-3%	-$93.8K	0.07%	161
2015 Q1	$3.47M	Buy	55,714 +12,360	+29%	+$719K	0.08%	169
2014 Q4	$2.49M	Buy	43,354 +29,729	+218%	+$1.66M	0.07%	174
2014 Q3	$732K	Buy	+13,625	New	+$722K	0.02%	244

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return